Back
Grace Therapeutics Stock Price Chart
FREE Copy of "2025 Gold Forecast: A Perfect Storm for Demand"
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report here
Buy
59
GRCE
Grace Therapeutics
Last Price:
$2.69
Seasonality Move:
17.14%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is moderately bullish and GRCE is experiencing slight selling pressure.
Grace Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.81 | Sell |
| 20-day SMA: | 2.58 | Buy |
| 50-day SMA: | 2.42 | Buy |
| 200-day SMA: | 2.99 | Sell |
| 8-day EMA: | 2.73 | Sell |
| 20-day EMA: | 2.62 | Buy |
| 50-day EMA: | 2.61 | Buy |
| 200-day EMA: | 2.92 | Sell |
Grace Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 54.72 | Buy |
| Chaikin Money Flow: | -2680 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.14 - 2.82) | Buy |
| Bollinger Bands (100): | (2.33 - 3.65) | Sell |
Grace Therapeutics Technical Analysis
| May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Grace Therapeutics Stock
Is Grace Therapeutics Stock a Buy?
-
Grace Therapeutics share price is 2.70 while GRCE 8-day simple moving average is 2.81, which is a Sell signal.
-
The stock price of GRCE is 2.70 while Grace Therapeutics 20-day SMA is 2.58, which makes it a Buy.
-
Grace Therapeutics 50-day simple moving average is 2.42 while GRCE share price is 2.70, making it a Buy technically.
-
GRCE stock price is 2.70 and Grace Therapeutics 200-day simple moving average is 2.99, creating a Sell signal.
GRCE Technical Analysis vs Fundamental Analysis
Buy
59
Grace Therapeutics (GRCE)
is a Buy
Is Grace Therapeutics a Buy or a Sell?
-
Grace Therapeutics stock is rated a BuyThe current Grace Therapeutics [GRCE] share price is $2.70. The Score for GRCE is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Grace Therapeutics Stock Info
Market Cap:
37M
Price in USD:
2.70
Share Volume:
14K
Grace Therapeutics 52-Week Range
52-Week High:
4.97
52-Week Low:
1.75
Buy
59
Grace Therapeutics (GRCE)
is a Buy
Grace Therapeutics Share Price Forecast
-
What is the Grace Therapeutics stock price today?The Grace Therapeutics stock price is 2.70 USD today.
-
Will GRCE stock go up or go down?Grace Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Grace Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Grace Therapeutics is not overvalued.
Is Grace Therapeutics Stock a Buy?
-
Grace Therapeutics share price is 2.70 while GRCE 8-day exponential moving average is 2.73, which is a Sell signal.
-
The stock price of GRCE is 2.70 while Grace Therapeutics 20-day EMA is 2.62, which makes it a Buy.
-
Grace Therapeutics 50-day exponential moving average is 2.61 while GRCE share price is 2.70, making it a Buy technically.
-
GRCE stock price is 2.70 and Grace Therapeutics 200-day simple moving average is 2.92, creating a Sell signal.
Fundamental Analysis of Grace Therapeutics
Is Grace Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.18 per share, and an increase next year of $0.34 per share.
Technical Analysis of Grace Therapeutics
Should I short Grace Therapeutics stock?
-
GRCE Moving Average Covergence Divergence (MACD) indicator is 0.11, suggesting Grace Therapeutics is a Buy
-
Grace Therapeutics Relative Strength Index (RSI) is 54.72, which suggest Grace Therapeutics is overbought
-
The Bollinger Bands (25) for Grace Therapeutics is (2.14 - 2.82), which suggest Grace Therapeutics is a Sell
-
The Bollinger Bands (100) for Grace Therapeutics is (2.33 - 3.65), which suggest Grace Therapeutics is a Sell
* Grace Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.